ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,839, issued on May 19, was assigned to Sangamo Therapeutics Inc. (Richmond, Calif.).
"Compositions for the treatment of Fabry disease" was invented by Marshall W. Huston (Richmond, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides expression constructs comprising a GLA transgene encoding the at least one Alpha-Gal A protein for use in expressing Alpha-Gal A proteins and preventing, inhibiting or treating Fabry disease or one or more symptoms associated with Fabry disease."
The patent was filed on Jan. 3, 2020, under Application No. 16/734,271.
*For further information, including images, charts and tables, please ...